Healthcare Community
Our community narratives are driven by numbers and valuation.
Healthcare Investing Ideas
Focusing On Presbyopia Treatments May Open New Markets But Faces Competition And Economic Uncertainties
Key Takeaways Strategic investments in new clinics and geographic diversification aim to drive revenue growth while mitigating regional economic risks. Expansion into lens-based treatments and potential M&A activities position EuroEyes for revenue and earnings enhancement through market growth and strategic partnerships.Read more
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AN
HK$6.31
49.4% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
5.34% p.a.
Profit Margin
12.82%
Future PE
20.04x
Share price in 2028
HK$6.67
